Bioorganic & Medicinal Chemistry Letters 2008-02-01

N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.

Holly L Deak, John R Newcomb, Joseph J Nunes, Christina Boucher, Alan C Cheng, Erin F DiMauro, Linda F Epstein, Paul Gallant, Brian L Hodous, Xin Huang, Josie H Lee, Vinod F Patel, Stephen Schneider, Susan M Turci, Xiaotian Zhu

Index: Bioorg. Med. Chem. Lett. 18(3) , 1172-6, (2008)

Full Text: HTML

Abstract

N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein.

Related Compounds

  • 4-Methyl-3-nitrobe...

Related Articles:

New low-density lipoprotein receptor upregulators acting via a novel mechanism.

1996-08-16

[J. Med. Chem. 39(17) , 3343-56, (1996)]

Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.

2014-01-01

[PLoS ONE 9(3) , e91765, (2014)]

Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase.

2012-08-15

[Bioorg. Med. Chem. Lett. 22(16) , 5279-82, (2012)]

Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors

2008-01-01

[Bioorg. Med. Chem. Lett. 18 , 4713-5, (2008)]

More Articles...